Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00666562
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:45.261551+00:00
Published At
2016-03-28T00:00:00+00:00
Record Updated At
2017-11-17
Results Posted At
2016-03-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Stage I Bladder Cancer", "Stage II Bladder Cancer", "Stage III Bladder Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-11-17"
protocolSection.identificationModule.nctId
"NCT00666562"
protocolSection.identificationModule.officialTitle
"A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-03-28"

Study condition terms

  • Stage I Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Bladder Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.